TY - JOUR
T1 - "I Do My Best To Listen to Patients"
T2 - Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study)
AU - Stuckey, Heather L.
AU - Vallis, Michael
AU - Kovacs Burns, Katharina
AU - Mullan-Jensen, Christine B.
AU - Reading, Jean M.
AU - Kalra, Sanjay
AU - Wens, Johan
AU - Kokoszka, Andrzej
AU - Skovlund, Søren E.
AU - Peyrot, Mark
N1 - Funding Information:
Novo Nordisk Inc funded the DAWN2 study. Dr. Stuckey has received compensation from Novo Nordisk for developing the DAWN2 coding scheme, training/supervising coders, and conducting qualitative analysis, as well as travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Vallis has received research funding from AbbVie Inc and Pfizer Inc, and speaking honoraria from AbbVie; Bayer Pharmaceuticals Corp; Becton, Dickinson, and Co; Merck & Co, Inc; Novo Nordisk; and The Sanofi-Aventis Group. Dr. Burns has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Mullan-Jensen’s salary is paid by Novo Nordisk A/S, Copenhagen, Denmark. Ms. Reading has received funds from Novo Nordisk for conducting the coding of qualitative data. Dr. Kalra has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Wens has participated on the advisory panels of AstraZeneca, Bristol-Myers Squibb Co, and Eli Lilly and Co and has received travel reimbursement from Novo Nordisk for DAWN-related presentations and meetings. Dr. Kokoszka has received grants, speaking honoraria, and travel expenses from Novo Nordisk; and funding for research from Krka (Poland), Otsuka Pharmaceutical Co, Ltd, and Sumitomo Dainippon Pharma. Mr. Skovlund is an employee of Novo Nordisk A/S, Copenhagen, Denmark. Dr. Peyrot has received research grants and/or consulting fees from AstraZeneca, Bristol-Myers Squibb/Amylin, Calibra, Eli Lilly, Novo Nordisk, and Roche/Genentech; speaking honoraria from Novo Nordisk; and financial support from Novo Nordisk for his participation as the principal investigator of the DAWN2 study; and he has participated on advisory panels of Eli Lilly, GlaxoSmithKline, and Novo Nordisk. The authors have indicated that they have no other conflicts of interest with regard to the content of this article.
Publisher Copyright:
© 2015 The Authors.
PY - 2015/9/1
Y1 - 2015/9/1
N2 - Purpose The aim of this study was to describe the perspectives of diabetes care professionals regarding the roles and responsibilities of people with diabetes (PWD), health care professionals (HCPs), and the larger society to improve the provision of person-centered diabetes care. Methods The survey contained open-ended items about challenges of, successes of, and wishes for improvements in treating adults with diabetes. All responses were systematically coded using a schema developed and validated through multinational collaboration. Findings Participants were 4785 diabetes care professionals (physicians, nurses, and dietitians) from 17 countries. The data contained 2 distinct themes. One theme reflected the fact that the roles and responsibilities of HCPs are transitioning from those of one who "tells" to one who "listens" to PWD. Some ways that HCPs can "listen" to PWD and family members is to involve them in goals and to encourage self-management for the improvement of treatment. The second theme identified barriers to successful diabetes care, which include a lack of time and collaboration from HCPs, a lack of availability of resources for treatment, and a lack of psychosocial support. Implications The views of diabetes care professionals are in transition from a conventional hierarchic approach to a PCC approach. Further adoption of this approach would be facilitated by additional psychosocial training and educational/psychological resources, increased teamwork, and societal changes that would make it easier for people to live successfully with diabetes.
AB - Purpose The aim of this study was to describe the perspectives of diabetes care professionals regarding the roles and responsibilities of people with diabetes (PWD), health care professionals (HCPs), and the larger society to improve the provision of person-centered diabetes care. Methods The survey contained open-ended items about challenges of, successes of, and wishes for improvements in treating adults with diabetes. All responses were systematically coded using a schema developed and validated through multinational collaboration. Findings Participants were 4785 diabetes care professionals (physicians, nurses, and dietitians) from 17 countries. The data contained 2 distinct themes. One theme reflected the fact that the roles and responsibilities of HCPs are transitioning from those of one who "tells" to one who "listens" to PWD. Some ways that HCPs can "listen" to PWD and family members is to involve them in goals and to encourage self-management for the improvement of treatment. The second theme identified barriers to successful diabetes care, which include a lack of time and collaboration from HCPs, a lack of availability of resources for treatment, and a lack of psychosocial support. Implications The views of diabetes care professionals are in transition from a conventional hierarchic approach to a PCC approach. Further adoption of this approach would be facilitated by additional psychosocial training and educational/psychological resources, increased teamwork, and societal changes that would make it easier for people to live successfully with diabetes.
UR - http://www.scopus.com/inward/record.url?scp=84941184441&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84941184441&partnerID=8YFLogxK
U2 - 10.1016/j.clinthera.2015.06.010
DO - 10.1016/j.clinthera.2015.06.010
M3 - Article
C2 - 26169765
AN - SCOPUS:84941184441
SN - 0149-2918
VL - 37
SP - 1986-1998.e12
JO - Clinical therapeutics
JF - Clinical therapeutics
IS - 9
M1 - 2620
ER -